Comments on "Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study"

Radiother Oncol. 2024 Apr 20:110292. doi: 10.1016/j.radonc.2024.110292. Online ahead of print.NO ABSTRACTPMID:38648993 | DOI:10.1016/j.radonc.2024.110292
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Source Type: research